SEC Form 4 · accession 0001239241-15-000003

Juno Therapeutics, Inc. · JUNO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Anthony B Evnin

Director

Period of report

Jun 25, 2015

Accepted (ET)

Jun 29, 2015 · 9:23 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001594864

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2,F3	Jun 25, 2015	S	140,675	$48.39	D	1,025,991	I	By Funds
Common Stock^F4,F5	Jun 25, 2015	S	71,725	$49.19	D	954,266	I	By Funds
Common Stock^F6,F7	Jun 25, 2015	S	85,800	$50.26	D	868,466	I	By Funds
Common Stock^F8,F9	Jun 25, 2015	S	1,800	$50.99	D	866,666	I	By Funds
Common Stock^F10,F11	Jun 26, 2015	S	173,713	$46.57	D	692,953	I	By Funds
Common Stock^F12,F13	Jun 26, 2015	S	78,395	$47.55	D	614,558	I	By Funds
Common Stock^F14,F15	Jun 26, 2015	S	31,225	$48.31	D	583,333	I	By Funds
Common Stock	holding	—	—		—	75,000	D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Venrock Healthcare Capital Partners, L.P. ("VHCP") and VHCP Co-Investment Holdings, LLC ("VHCP Co-Invest") on May 18, 2015.
F10The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.11 to $47.10, inclusive.
F11Consists of 585,795 shares held by VHCP and 107,158 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
F12The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.11 to $48.10, inclusive.
F13Consists of 519,523 shares held by VHCP and 95,035 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
F14The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.11 to $48.95, inclusive.
F15Consists of 493,127 shares held by VHCP and 90,206 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.80 to $48.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) - (15) to this Form 4.
F3Consists of 867,333 shares held by VHCP and 158,658 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.80 to $49.71, inclusive.
F5Consists of 806,699 shares held by VHCP and 147,567 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.80 to $50.79, inclusive.
F7Consists of 734,167 shares held by VHCP and 134,299 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.80 to $51.11, inclusive.
F9Consists of 732,645 shares held by VHCP and 134,021 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.